BAYZF

PINK Bayer AG
Oct 3, 2026 · 4:27 AM ET EOD Market Closed

$52.79 ↑ +2.76 (+5.52%) Trading Up from the previous close of $50.03, and at the day’s high of $52.79

YTD change
+22.72%
vs 20-day SMA
-5.91%
vs 200-day SMA
+17.49%

Price ranges

Previous day
$52.79 $52.79
open $52.79 close $52.79
+$0.00 (+0.00%)
Today
$52.79 $52.79
$52.79
Past week
$50.03 $57.60
from $56.27 now $52.79
-$3.48 (-6.18%)
Past month
$50.03 $57.60
from $54.61 now $52.79
-$1.82 (-3.33%)
This year
$38.94 $61.38
from $43.02 now $52.79
+$9.78 (+22.72%)

Price & Performance

+5.34 (+11.25%) / 6M

$37.26$45.40$53.54$61.68Apr 8Jul 2Oct 2

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 62.3% away from all-time highs of $140.21
  • BAYZF is up 23% since the beginning of the year
  • BAYZF is up 55% over the past 12 months
  • BAYZF is down 3% over the past 1 month
  • 0% of all BAYZF investors are betting against BAYZF

BAYZF reads neutral: price sits above one of the two key moving averages, the 12-month move is +60.2%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes
EPS $0.2592
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Beta -0.25

Balance sheet & scale

IncomeN/A
Revenue$51.9B
Cash$4.9B
Debt$43.9M
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangePINK
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $51.9B

Bayer AG engages in the business of life science fields of healthcare and nutrition. It operates through the following segments: Crop Science, Pharmaceuticals, and Consumer Health. The Crop Science segment includes developing, producing, and marketing products in seeds and plant traits, crop protection, digital solutions, and customer services to promote sustainable agriculture. The Pharmaceuticals segment is involved in prescription products especially for cardiology and women’s health; specialty therapeutics in the areas of oncology, hematology, ophthalmology, and cell and gene therapy; diagnostic imaging equipment; and necessary contrast agents. The Consumer Health segment focuses on non-prescription products in the dermatology, nutritional supplements, digestive health, allergy, cough and cold, and pain and cardiovascular risk prevention categories. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.

Competitor comparison

TickerCompany PriceChange
SHECY Shin-Etsu Chemical Co Ltd Unsponsored ADR $19.33 +2.49%
BAYRY Bayer AG Sponsored ADR $12.64 -0.71%
DOW Dow, Inc. $27.97 +1.38%
SHWDY Resonac Holdings Corporation Unsponsored ADR $104.54 +6.67%
CSL Carlisle Companies Incorporated $329.34 +1.27%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.